GLP-1 medications, sold under brand names such as Ozempic and Wegovy, have been widely used to treat type 2 diabetes and aid weight-loss efforts. However, some scientists are now investigating how these medications may impact users’ sex lives. According to a recent poll, roughly one in five Americans reports taking or having taken a GLP-1.
A review published in Obesity Pillars in March 2026 proposed that GLP-1s may influence desire by impacting brain chemistry. Researchers suggest that these medications may lessen libido by affecting the brain’s reward pathways. James Simon, MD, an ob-gyn and reproductive endocrinologist, explains that GLP-1s contain semaglutide, a synthetic version of a naturally occurring hormone, which binds to GLP-1 receptors throughout the brain and body.
Other options, like Zepbound and Mounjaro, contain a different active ingredient called tirzepatide, which mimics both GLP-1 and a related hormone. On top of reporting reduced appetite and increased satiety, some patients have also found that these weight-loss medications quiet what they call “food noise.” Dr. Simon notes that the same parts of the brain that control appetite are also responsible for other reward-seeking behaviors, which could help explain why taking GLP-1s may decrease appetite for sex.
Early research suggests that GLP-1s may affect certain serotonin receptors, including one called 5-HT2C, which is thought to be a key player in the sexual side effects often experienced by those taking selective serotonin reuptake inhibitors (SSRIs). Dr. Simon says that while SSRIs are fantastic options for anxiety and depression, they can have a significant impact on sexual desire and orgasmic function in both men and women.
Pelvic Floor Function Matters
Pelvic-health physical therapist Iris Xu, PT, DPT, explains that sexual function isn’t just about hormones and brain chemistry, but also depends on the pelvic floor, a group of muscles that support the bladder and bowel, among other organs. Weight loss, including that from GLP-1s, can improve pelvic-floor function because reduced abdominal pressure means the muscles don’t have to work as hard to support the pelvic organs.
A 2024 study published in Archives of Gynecology and Obstetrics found that women carrying more fat, particularly in the pelvic area, had weaker pelvic floor muscles than those with less.
Research specifically examining GLP-1 medications and pelvic-floor outcomes remains limited, but the available data points to this being a likely outcome. Dr. Xu notes that losing too much lean mass may weaken pelvic floor support, affecting arousal, orgasm intensity, or overall sexual function. Rapid weight loss can also shift how users feel in their body, which can impact sexual desire and pleasure.
Related Post: New Weight Loss Pills Compared
Body Confidence and Desire
Sex and relationship therapist Joy Berkheimer, PhD, LMFT, says that weight loss does not automatically translate to increased body confidence and desire. She explains that sexual desire and pleasure are often closely tied to embodiment, so a lack of embodiment can impact intimacy. For some, GLP-1s can bring about physical changes that increase sexual desire, such as improved energy, hormone balance, and physical comfort.
Dr. Simon notes that addressing underlying health issues, such as obesity, insulin resistance, type 2 diabetes, and polycystic ovarian syndrome (PCOS), may benefit sexual health. He says that as fat mass decreases and inflammation drops, people may feel more comfortable, energetic, and ultimately sexier. Additionally, as body composition improves, hormone levels may shift in ways that boost sexual desire and function.
GLP-1 medications have also been shown to improve markers associated with vascular health, including blood pressure. Healthy blood flow is essential to arousal in people of all genders, says Dr. Simon. For those with vaginas, it supports clitoral engorgement, lubrication, and vaginal expansion. Board-certified bariatric surgeon and obesity medicine specialist Betsy Dovec, MD, FACS, DBOM, notes that improved metabolic health can increase energy levels and make people feel more comfortable in their bodies.
Social Factors Influence Desire
Social, cultural, and interpersonal relationship factors can also lead to increased desire while on a GLP-1. Social psychologist Justin Lehmiller, PhD, notes that confidence can have huge impacts on sexual satisfaction, making it easier to surrender to pleasure and communicate about sexual needs and desires.
Dr. Dovec notes that sexual health isn’t a frivolous concern, and shifts in sexual desire and function can offer useful information about what’s happening in the body. She encourages users to talk to their provider if they experience changes in their sex life, as these shifts can be temporary or solvable with a provider’s help. Sometimes, the solution is as simple as adjusting GLP-1 dosage or timing, or suggesting lifestyle changes to support hormone balance. Dr. Dovec suggests that users can start the conversation by saying, “Something feels different,” or “I don’t feel like myself sexually.”
Weight-Loss Magnitude, Body Image, and Sexual Confidence
Clinical data show GLP-1 users typically lose roughly 10% to 20% of total body weight, varying by drug, dose, and treatment duration. Cultural narratives often suggest that rapid slimming will instantly increase self-esteem, yet many patients report feeling unfamiliar in their altered bodies. This sense of unfamiliarity can arise because long-standing body policing makes swift physical changes unsettling, potentially affecting intimacy. The disconnect between expected confidence and actual embodiment may influence sexual desire independent of hormonal or muscular factors.
